Logo
  • basket-banner

    Opps! Your Basket is empty

Treatmentsicon

0

Producticon

0

Semaglutide + B12

Injectable GLP-1s
Images for illustrative purposes only
  • check-iconAppetite and craving control
  • check-iconConvenient weekly injection
  • check-iconIncludes added B12 for energy support
  • check-iconPharmacy-compounded in the U.S.

Semaglutide + B12

Category:Injectable GLP-1s

Compounded Semaglutide contains the same active ingredient as Wegovy® and Ozempic®, used to treat type 2 diabetes and support weight loss of up to 15% of body weight.
This GLP-1 medication helps regulate blood sugar, reduce appetite, and slow digestion. It's combined with vitamin B12 to support energy levels and metabolic function—delivered in a flexible vial-and-syringe format for weekly use.

Fetching Data...

doctor-pana
Free tracked delivery

Delivered in plain packaging

doctor-pana
Fast Turnaround

We aim to dispatch within 24-48 hrs

Frequently Asked Questions for Semaglutide + B12

Further Information

How it works

Semaglutide is part of a class known as GLP-1 receptor agonists. It works with natural pathways in the body and is designed to help:

  • Reduce appetite and cravings

  • Slow digestion for improved satiety

  • Encourage portion control and balance

  • Support healthy weight management

The added B12 is included to help maintain natural energy levels.

How to use

  • Inject subcutaneously once per week.
  • Rotate injection sites (abdomen, thigh, or upper arm).
  • Store in a cool, dry place as instructed.
  • Follow the usage directions included with your package.

Side effects & precautions

Some users may experience temporary effects such as:

  • Mild nausea or upset stomach

  • Constipation or diarrhea

  • Occasional headache or fatigue

These are usually mild and improve as the body adjusts. If severe or persistent effects occur, discontinue use and seek medical attention.

  • Verify Approval for www.lovelymeds.com

Lovely Meds provides GLP-1 and other medications through licensed U.S. pharmacies. Compounded medications, including semaglutide and tirzepatide, are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality. Ozempic® (semaglutide), Wegovy® (semaglutide), Mounjaro® (tirzepatide), and Zepbound™ (tirzepatide) are FDA-approved; however, compounded versions may be prescribed by independent licensed physicians when clinically appropriate, such as during FDA-declared shortages or to meet specific patient needs.

All prescription products require an online evaluation by an independent licensed medical professional, who will determine if treatment is appropriate. Prescriptions are filled by partner pharmacies unless you request an alternative, and product packaging may differ from images shown.

Compounded medications are custom preparations made by state-licensed pharmacies. They are not manufactured or endorsed by the original brand manufacturer and may differ in form, strength, or appearance. These products are dispensed under U.S. state pharmacy laws and in accordance with FDA guidance where applicable. Patients should carefully review potential risks, benefits, and alternatives with their prescribing clinician before use.

By using Lovely Meds services, you consent to the limited use of de-identified data for advertising purposes on platforms such as Google and Facebook to reach new patients or exclude existing ones. You may opt out of marketing emails at any time by using the unsubscribe link provided or by contacting us directly at hello@lovelymeds.com.

© Lovely Meds Inc. 2025

logo